← Back to Screener
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)
Price$4.77
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-88.46%
Price vs S&P 500 (4W)-23.49%
VGM Score24.48
Market Capitalization$9.69M
All Metrics
Book Value / Share (Quarterly)$0.13
P/TBV (Annual)0.62x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.23
Price vs S&P 500 (YTD)-75.87%
EPS (TTM)$-16.49
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-16.49
EPS (Annual)$-14.80
ROI (Annual)-102.34%
Cash / Share (Quarterly)$0.20
ROA (Last FY)-77.51%
EBITD / Share (TTM)$-10.72
ROE (5Y Avg)-752.92%
Cash Flow / Share (Annual)$-0.26
P/B Ratio1.10x
P/B Ratio (Quarterly)1.36x
Net Income / Employee (Annual)$-3,951,200
Net Interest Coverage (TTM)-14.21x
ROA (TTM)-132.17%
EPS Incl Extra (Annual)$-14.80
Current Ratio (Annual)3.61x
Quick Ratio (Quarterly)2.63x
3-Month Avg Trading Volume0.08M
52-Week Price Return-46.00%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.12
52-Week High$41.80
EPS Excl Extra (Annual)$-14.80
26-Week Price Return-72.53%
Quick Ratio (Annual)3.38x
13-Week Price Return-40.54%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)2.87x
Enterprise Value$8.74M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.36
3-Month Return Std Dev87.00%
Net Income / Employee (TTM)$-4,247,600
ROE (Last FY)-120.46%
Net Interest Coverage (Annual)-10.63x
EPS Basic Excl Extra (Annual)$-14.80
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.25x
EPS Incl Extra (TTM)$-16.49
ROI (TTM)-123.95%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.24
Price vs S&P 500 (52W)-74.20%
Year-to-Date Return-64.93%
5-Day Price Return6.08%
EPS Normalized (Annual)$-14.80
ROA (5Y Avg)-100.04%
Month-to-Date Return-21.91%
Cash Flow / Share (TTM)$-0.00
EBITD / Share (Annual)$-15.25
LT Debt / Equity (Annual)0.13x
ROI (5Y Avg)-150.20%
LT Debt / Equity (Quarterly)0.18x
EPS Basic Excl Extra (TTM)$-16.49
P/TBV (Quarterly)1.41x
P/B Ratio (Annual)0.61x
Book Value / Share (Annual)$0.25
Price vs S&P 500 (13W)-50.29%
Beta1.57x
Revenue / Share (TTM)$0.00
ROE (TTM)-160.06%
52-Week Low$4.55
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-1.77est. -1.97
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.13
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares | — | — | D | $4.77 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. The company's pipeline of three products targets multiple indications including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, and Epidermolysis Bullosa.